Sandler Laura Lee
SEC insider (Form 3/4/5 filer). CIK 0002075401. Chief Operating Officer at Oruka Therapeutics, Inc. (ORKA). 26 reported Form 4/5 transactions since Sep 2024; latest on Sep 15, 2026. Located in MENLO PARK, CA.
Companies Sandler Laura Lee has filed insider reports for
- Oruka Therapeutics, Inc. (ORKA): Officer, Chief Operating Officer
Sandler Laura Lee
CIK: 0002075401
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Oruka Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (26 total)
- Sep 15, 2026ORKA
Oruka Therapeutics, Inc.
SaleDirect906 shares at avg. $95.71$87K - Sep 1, 2026ORKA
Oruka Therapeutics, Inc.
ExerciseDirect5K shares at avg. $7.80$39K - Sep 1, 2026ORKA
Oruka Therapeutics, Inc.
SaleDirect1K shares at avg. $91.05$91K - Sep 1, 2026ORKA
Oruka Therapeutics, Inc.
SaleDirect4K shares at avg. $92.01$368K - Jul 1, 2026ORKA
Oruka Therapeutics, Inc.
SaleDirect500 shares at avg. $95.47$48K - Jul 1, 2026ORKA
Oruka Therapeutics, Inc.
ExerciseDirect5K shares at avg. $7.80$39K - Jul 1, 2026ORKA
Oruka Therapeutics, Inc.
SaleDirect2.3K shares at avg. $94.75$214K - Jul 1, 2026ORKA
Oruka Therapeutics, Inc.
SaleDirect2.2K shares at avg. $93.85$210K - Jun 15, 2026ORKA
Oruka Therapeutics, Inc.
SaleDirect600 shares at avg. $69.69$42K - May 1, 2026ORKA
Oruka Therapeutics, Inc.
SaleDirect100 shares at avg. $68.48$7K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 15, 2026 | ORKA Oruka Therapeutics, Inc. | Sale | 906 | $95.71 | $86,713 | Direct |
| Sep 1, 2026 | ORKA Oruka Therapeutics, Inc. | Exercise | 5,000 | $7.80 | $39,000 | Direct |
| Sep 1, 2026 | ORKA Oruka Therapeutics, Inc. | Sale | 1,000 | $91.05 | $91,048 | Direct |
| Sep 1, 2026 | ORKA Oruka Therapeutics, Inc. | Sale | 4,000 | $92.01 | $368,054 | Direct |
| Jul 1, 2026 | ORKA Oruka Therapeutics, Inc. | Sale | 500 | $95.47 | $47,736 | Direct |
| Jul 1, 2026 | ORKA Oruka Therapeutics, Inc. | Exercise | 5,000 | $7.80 | $39,000 | Direct |
| Jul 1, 2026 | ORKA Oruka Therapeutics, Inc. | Sale | 2,263 | $94.75 | $214,410 | Direct |
| Jul 1, 2026 | ORKA Oruka Therapeutics, Inc. | Sale | 2,237 | $93.85 | $209,933 | Direct |
| Jun 15, 2026 | ORKA Oruka Therapeutics, Inc. | Sale | 600 | $69.69 | $41,814 | Direct |
| May 1, 2026 | ORKA Oruka Therapeutics, Inc. | Sale | 100 | $68.48 | $6,848 | Direct |
1-10 of 26 transactions